Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × axatilimab × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Myeloid 2 Breast 2 Tumor-Agnostic 1 Lymphoid 1

Conditions

Hodgkin Disease 1

Interventions

Cyclophosphamide 172 Rituximab 146 venetoclax 82 Specimen Handling 80 fludarabine 79 Vincristine 69 obinutuzumab 67 Prednisone 67 Doxorubicin 65 Biopsy 60 Magnetic Resonance Spectroscopy 59 Lenalidomide 53 zanubrutinib 51 Dexamethasone 50 Cytarabine 46 Methotrexate 44 blinatumomab 40 acalabrutinib 37 Bendamustine Hydrochloride 35 Etoposide 34 Immunotherapy, Adoptive 33 fludarabine phosphate 32 ibrutinib 30 glofitamab 28 polatuzumab vedotin 26 Gemcitabine 25 pirtobrutinib 24 orelabrutinib 23 Injections 21 pembrolizumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05723055 2025-11-26

NAHL

University of Utah

Phase 2 Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡